Evidence map›Paper›PMID 40253446›Full record

ArticleScientific reports2025

The role of adherent-to-suspension transition factors in clear cell renal cell carcinoma progression: a comprehensive analysis.

Chenglong Xu, Haotian Wei, Yue Wang, Xiaocheng Ma, Qi Li, Yingjie Bi, Zifei Li, Zhaochen Li, Shimiao Zhu, Jing Tian and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chenglong XuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Haotian WeiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yue WangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Xiaocheng MaDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Qi LiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yingjie BiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zifei LiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhaochen LiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Shimiao ZhuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Jing TianDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. 13821777622@163.com.
Changyi QuanDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. quanchangyi@tmu.edu.cn.
Shiyong QiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. yongshiqi@126.com.

Funding

The Education Commission Research Project of Tianjin 2023ZD008The Education Commission Research Project of Tianjin 2024KJ193Tianjin Health Research Project TJWJ2024ZD002
6 · The paper itself

Abstract

Recent studies have identified a biological process called adherent-to-suspension transition (AST) as a key factor in promoting metastasis. The involvement of AST in the progression of clear cell renal cell carcinoma (ccRCC) remains largely unexplored. We comprehensively investigated the overall landscape of all 20 AST factors at the pan-cancer level. The risk stratification method and the prognostic model based on AST factors were established with consensus clustering analysis and LASSO regression algorithm. The potential molecular mechanism of AST was further investigated by multi-omics analysis and cell experiments. We found that AST factors play distinct roles in different cancer types. Consequently, we utilized AST factors to develop a risk stratification method and a prognostic model, which can effectively guide the treatment of ccRCC patients. We proposed that the promotion of AST is facilitated by SPIB through the SAA1-AKT pathway, enhancing the likelihood of ccRCC metastasis, and conducted rigorous analyses using multi-omics data and cellular experiments. Our study presents a novel risk stratification method and prognostic model for ccRCC. And we identified the SPIB-SAA1-AKT pathway as one of the potential mechanisms by which AST factors promote ccRCC metastasis.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsCell Line, TumorDisease ProgressionFemaleGene Expression Regulation, NeoplasticHumansMalePrognosisProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-aktAdherent-to-suspension transitionClear cell renal cell carcinomaMulti-omics studyPan-cancer analysisPrognostic model

Identifiers

PMID40253446
PMCPMC12009395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.